This article provides a comprehensive overview of modern ligand-based drug design (LBDD) and its critical role in oncology drug discovery.
This article provides a comprehensive overview of computer-aided drug design (CADD) principles and their transformative application in oncology drug development.
Quantitative PCR (qPCR) is a cornerstone of molecular diagnostics and biomarker validation in oncology, yet its reproducibility across different research centers remains a significant challenge.
This article provides a comprehensive comparison of quantitative PCR (qPCR) and digital PCR (dPCR) platforms for biomarker analysis, addressing the critical needs of researchers and drug development professionals.
This article provides a comprehensive overview for researchers and drug development professionals on the synergistic relationship between Quantitative PCR (qPCR) and Fluorescence In Situ Hybridization (FISH).
This article provides a comprehensive comparison of quantitative PCR (qPCR) and NanoString nCounter for validating copy number alterations (CNAs), a critical step in genomic biomarker development.
This article provides a comprehensive guide for researchers and drug development professionals on enhancing qPCR sensitivity for early cancer detection.
Accurate quantitative PCR (qPCR) is foundational to modern clinical diagnostics and biomedical research, yet its reliability is frequently compromised by inhibitors present in complex clinical samples such as blood, tissues,...
This article provides a comprehensive guide for researchers and drug development professionals on optimizing reaction conditions to overcome the significant challenges in rare cancer cell detection.
Accurate quantification in quantitative PCR (qPCR) is fundamentally dependent on the correct setting of two critical parameters: the baseline and the quantification threshold.